Sport-related concussion (SRC) is a prevalent injury in both recreational and organized sports. Over the past few decades, there has been significant advancement in our scientific comprehension of SRC, leading to the establishment of clinical recommendations for its diagnosis, assessment, and management. As the need for knowledgeable healthcare professionals to deliver evidence-based care for athletes […]
Read More
Alopecia areata is a prevalent autoimmune skin disease characterized by the development of patches of non-scarring hair loss. According to the National Alopecia Areata Foundation, nearly 7 million people in the United States (US) and 160 million worldwide are affected by alopecia areata or will be affected by it at some point. Currently, it is […]
Read More
Among all women in the United States, breast cancer is the second most common cancer and the second leading cause of cancer-related deaths. In 2023, an estimated 43,170 women lost their lives to breast cancer. The incidence of breast cancer has been gradually increasing among women aged 40 to 49 years from 2000 to 2015, […]
Read More
Pompe disease, also known as acid maltase disease and glycogen storage disease II, is a rare genetic disorder that results in progressive weakness in the heart and skeletal muscles. This debilitating condition is caused by mutations in a gene responsible for producing an enzyme called acid alpha-glucosidase (GAA). This enzyme plays a crucial role in […]
Read More
International Infection Prevention Week (IIPW) is an annual observance held every third week of October, with this year’s event taking place from October 20 to 26. The purpose of IIPW 2024 is to educate stakeholders and the general public on the critical importance of preventing the spread of illnesses and infectious agents. Infections, ranging from […]
Read MoreWelcome to the newest installment of our Guidelines+ Monographs Series. Today, we will be exploring the medication naltrexone, specifically the injectable form marketed under the brand name Vivitrol by Alkermes, Inc. Vivitrol is an opioid antagonist that was first approved in 2006. It is prescribed for the treatment of alcohol dependence and to block the […]
Read More
In the latest edition of the Guidelines International Series, we explore the most recent guidelines published by the prestigious International Myeloma Working Group (IMWG). The IMWG is well known for its series of guidelines and recommendations that focus on the management and treatment of multiple myeloma and related disorders. With numerous research studies and treatment […]
Read More
According to the Centers for Disease Control (CDC), nearly 6.7 million adults aged 20 years or older in the United States are affected by heart failure. In 2022, heart failure accounted for 13.9% of all causes of mortality. Heart failure is a serious condition with no known cure, but various treatments such as healthy lifestyle […]
Read MoreWelcome to the latest edition of our Guidelines+ Monographs Series. In this installment, we will delve into the medication brexpiprazole, marketed under the brand name Rexulti by Otsuka America Pharmaceutical, Inc and Lundbeck LLC. Rexulti, an atypical antipsychotic, received initial approval in 2015. It is indicated for use as an adjunctive therapy to antidepressants for […]
Read More
The American Society of Clinical Oncology (ASCO) is committed to developing dynamic guidelines for specific topic areas that continuously evolve with new research and evidence, resulting in frequent changes in recommended clinical practices. These living guidelines are regularly updated by a standing expert panel that systematically reviews health literature on an ongoing basis. In 2022, […]
Read More